| Net Cash Provided by (Used in) Operating Activities |
$193,651 |
USD |
-13329% |
Q4 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$260,000 |
USD |
15658% |
Q4 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
300,000,000 |
shares |
0% |
Q4 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
34,430,605 |
shares |
38% |
Q4 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$66,349 |
USD |
|
Q4 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$103,580 |
USD |
17728% |
Q4 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$1,496,440 |
USD |
62% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$1,496,440 |
USD |
62% |
Q3 2025 |
FY 2025 |
| Depreciation |
$458 |
USD |
0% |
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$1,496,440 |
USD |
62% |
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
20,000,000 |
shares |
0% |
Q4 2025 |
Q1 2026 |
| Additional Paid in Capital |
$25,974,173 |
USD |
8.1% |
Q4 2025 |
Q1 2026 |
| Share-based Payment Arrangement, Expense |
$62,500 |
USD |
|
Q2 2025 |
Q3 2025 |
| Interest Expense |
$71,000 |
USD |
292% |
Q4 2025 |
Q1 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
Q1 2026 |